Skip to main content

Find Clinical Trials

Home
Conditions
Infiltrating Urothelial Carcinoma

Clinical trial condition

Infiltrating Urothelial Carcinoma

Explore clinical trials studying Infiltrating Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Infiltrating Urothelial Carcinoma trial results

Completed

I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras Mutations

NCT02818725

Conditions: Infiltrating Urothelial Carcinoma, KRAS Gene Mutation
Locations: Hopital Saint Andre Bordeaux, France

Institut Bergonie Bordeaux, France

Centre Francois Baclesse Caen, France

Hopital Henri Mondor Créteil, France

View all 17 locations

View Trial Details

KRAS Gene Mutation (1)